ROSEN, GLOBAL INVESTOR COUNSEL, encourages investors in Enochian BioSciences, Inc. suffering losses to … | New
NEW YORK, Aug. 07, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of Enochian BioSciences, Inc. (NASDAQ:ENOB) securities between the January 17, 2018 and June 27, 2022, both dates inclusive, (the “Class Period”), including the common shares issued by Enochian pursuant to a private placement on or about February 16, 2018, the material deadline for September 26, 2022 for the main applicant.
SUCH AS: If you purchased Enochian BioSciences securities during the Class Period, you may be entitled to compensation without payment of any disbursements or fees through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Enochian BioSciences class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information. A class action lawsuit has already been filed. If you wish to act as a lead plaintiff, you must move the Court no later than September 26, 2022. A lead plaintiff is a representative party acting on behalf of other class members to direct litigation.
WHY ROSEN LAW: We encourage investors to select qualified lawyers with proven track records in leadership roles. Often, companies issuing reviews do not have comparable experience, resources, or significant peer recognition. Many of these firms do not actually handle securities class action lawsuits, but are merely middlemen who refer clients or partner with law firms that actually litigate the cases. Be wise in choosing lawyers. Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder derivative litigation. Rosen Law Firm has reached the largest securities class action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has ranked in the top 4 every year since 2013 and has recovered hundreds of million dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) co-founder and inventor, Serhat Gumrukcu , engaged in various frauds; (2) Gumrukcu was not a licensed physician anywhere in the world; (3) as a result of the foregoing, Gumrukcu’s alleged contributions to Enochian lacked reasonable basis; (4) due to the foregoing, Enochian had exaggerated its business prospects; (5) Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (6) as a result of the foregoing, defendants’ positive statements regarding Enochian’s business, operations and prospects were materially misleading and/or lacked reasonable basis. When the real details entered the market, the lawsuit claims investors suffered damages.
To join the Enochian BioSciences class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6517 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information.
No class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent party member and do nothing at this point. An investor’s ability to participate in any potential future upturn does not depend on their status as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertisement. Previous results do not guarantee a similar result.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
Copyright 2022 GlobeNewswire, Inc.